糖原合酶激酶 3 (GSK-3) 是一种多功能丝氨酸/苏氨酸激酶,由两种亚型组成,即 α 和 β。它是受体酪氨酸激酶、细胞因子和 Wnt 信号通路的高度保守负调节剂。这些通路的刺激会抑制 GSK-3 调节各种下游效应因子,包括转录因子、营养传感器、糖原合成、线粒体功能、昼夜节律和细胞命运。GSK-3 还调节响应 T 细胞受体激活的选择性剪接,最近的磷酸化蛋白质组学研究表明,多种剪接因子和 RNA 生物合成调节因子以 GSK-3 依赖的方式进行磷酸化。
GSK-3 的功能障碍或异常活动会导致多种疾病,如阿尔茨海默病 (AD) 和其他神经退行性疾病,以及其他类型的疾病,如糖尿病、心血管疾病和癌症。GSK-3 还与针对病原体的先天免疫反应有关,这使得 GSK-3 成为治疗干预的绝佳靶点。
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase consisting of two isoforms, alpha and beta. It is a highly conserved negative regulator of receptor tyrosine kinase, cytokine, and Wnt signaling pathways. Stimulation of these pathways inhibits GSK-3 to modulate diverse downstream effectors that include transcription factors, nutrient sensors, glycogen synthesis, mitochondrial function, circadian rhythm, and cell fate. GSK-3 also regulates alternative splicing in response to T-cell receptor activation, and recent phosphoproteomic studies have revealed that multiple splicing factors and regulators of RNA biosynthesis are phosphorylated in a GSK-3-dependent manner.
The malfunction or aberrant activity of GSK-3 leads to several of disorders, such as Alzheimer's disease (AD) and other neurodegenerative pathologies, and other type of diseases as diabetes, cardiovascular disorders and cancer. GSK-3 is also related to innate immune response against pathogens, which makes GSK-3 an excellent target for therapeutic intervention.
6-Me-ATP(N6-Methyl-ATP)是一种 N6 修饰的 ATP 衍生物,对 GSK3 表现出良好的结合亲和力,可作为 GSK3β 催化其底物肽磷酸化的磷酸基团供体,并可用于阿尔茨海默病的相关研究。
6-Me-ATP (N6-Methyl-ATP) trisodium solution (100 mM) 是一种 N6 修饰的 ATP 衍生物,对 GSK3 显示出良好的结合亲和力,可作为 GSK3β 催化其底物肽磷酸化的磷酸基团供体。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号